среда, 29 июня 2016 г.

BNP Paribas Reiterates Outperform Rating for Shire PLC

BNP Paribas Reiterates Outperform Rating for Shire PLC


's stock had its "outperform" rating reissued by equities researchers at BNP Paribas in a report released on Monday. They presently have a GBX 5,700 price objective on the biopharmaceutical company's stock.



from Biotech News